CFDE Data Portal | Search HTR5BP

	Label	Description
	HTR5BP associations Collection (Entity type)	Associations for HTR5BP_associations
	HTR5BP associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	HTR5BP Gene (Entity type)	ENSG00000125631 - 5-hydroxytryptamine receptor 5B, pseudogene
	GSE107144 PPT 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE209533 disulfiram 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GPR75 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	TAS2R50 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG

HTR5BP associations

Associations for HTR5BP_associations

HTR5BP associations.tsv

A file from IDG as part of the Harmonizome project

HTR5BP

ENSG00000125631 - 5-hydroxytryptamine receptor 5B, pseudogene

GSE107144 PPT 0 v 2 human up

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 9 human dn

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 2 v 7 human dn

A Gene Set from LINCS

GSE218060 decitabine T cell 7 v 3 human dn

A Gene Set from LINCS

GSE209533 disulfiram 0 v 1 human up

A Gene Set from LINCS

GPR75 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

TAS2R50 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.